Where does Banshi Saboo practice?

Banshi Saboo is affiliated with Diabetes care model in Unknown, Unknown, Global.

What is Banshi Saboo's H-index?

Banshi Saboo has an H-index of 57, placing them in the top 3% of medical professionals worldwide.

What is Banshi Saboo's medical specialty?

Banshi Saboo specializes in Medicine.

Is Banshi Saboo verified by MDRPedia?

Yes, Banshi Saboo is a verified MASTER tier physician on MDRPedia, the global authority for medical reputation.

Banshi Saboo — MDRPedia

Top 3% — Master

Banshi Saboo

Medicine

Global

57 H-Index

430 Total Impact

Share or Embed Profile

Profile URL

Quick Share

Embed Style

Minimal link badge for your website

<a href="https://mdrpedia.com/doctors/banshi-saboo" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:8px 16px;background:#1a1a2e;border:1px solid rgba(255,255,255,0.1);border-radius:8px;text-decoration:none;color:#fff;font-family:system-ui,sans-serif;font-size:14px;"><span style="color:#00cc66;">●</span>Banshi Saboo — MDRPedia</a>

Preview:

● Banshi Saboo — MDRPedia

Copied!

Overview

Banshi Saboo is a medicine specialist with an H-index of 57 at Diabetes care model (Member). Has been published in The Lancet Diabetes & Endocrinology, International Journal of Molecular Sciences. Based in Unknown, Unknown, Global.

Biography

Subrahmanyam Karuturi is an Indian consultant physician, diabetologist, and research scholar born in 1981 specialising in diabetes and internal medicine. He currently serves as chief physician at Kify Hospital, Rajahmundry, India. He is also the founder of Kify Hospital.

Affiliations & Institutions

Diabetes care model

Member

Research Impact

5 Publications

0 Total Citations

Publication Timeline

Published In

Diabetes CareLancet Diabetes EndocrinolObes RevJ Clin Lipidol

Key Publications

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Diabetes Care 2019

DOI PubMed

Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.

J Clin Lipidol 2024

DOI PubMed

Areas of Expertise

Medical Specialties

Medicine

A. C. Dhariwal , MD

Medicine

Global

173360y

M. A. Q. Khan , MD

Medicine

Global

10400y

A. G. Unnikrishnan , MD

Medicine

Global

85011y

A. K. Das , MD

Medicine

Global

0500y

Banshi Saboo

Share or Embed Profile

Overview

Biography

Affiliations & Institutions

Diabetes care model

Research Impact

Publication Timeline

Published In

Key Publications

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.

International Consensus on Use of Continuous Glucose Monitoring.

Obesity in South and Southeast Asia-A new consensus on care and management.

Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.

Areas of Expertise

Medical Specialties

Related Specialists

A. C. Dhariwal , MD

M. A. Q. Khan , MD

A. G. Unnikrishnan , MD

A. K. Das , MD